DNTH Market Cap & Key Metrics
Dianthus Therapeutics, Inc.
$78.10
-$0.65(-0.83%)
46
Overall
60
Value
36
Tech
44
Quality
Market Cap
$4.40B
Volume
1.19M
52W Range
$32.22 - $117.88
Target Price
$140.13
DNTH market cap is $4.40B. This page lists Dianthus Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
DNTH Key Metrics
- Market cap
- $4.40B
- EPS estimate, current year
- $-3.81
- EPS growth, 3-year
- +41.18%
- Value score
- 60
- Quality score
- 44
- Technical score
- 36
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.04M | $6.24M | $2.83M | $6.42M | - |
| EBITDA | -$161.92M | -$84.55M | -$47.82M | -$29.56M | -$13.09M |
| EPS | $-4.20 | $-2.55 | $-8.45 | $-20.64 | $-20.64 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNTH | $78.10 | -0.8% | 1.19M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Dianthus Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW